| HbA1c % | mmol/mol | eAG mg/dL | eAG mmol/L | Interpretation |
|---|
About HbA1c — Interpretation & Diabetes Targets
HbA1c (Glycated Haemoglobin) reflects average blood glucose over the preceding 2–3 months and is the gold standard for long-term glycaemic monitoring in diabetes. It is expressed as a percentage (NGSP/DCCT standard) or in mmol/mol (IFCC standard). The conversion formula is: mmol/mol = (% − 2.15) × 10.929. The estimated Average Glucose (eAG) can be derived as: eAG (mg/dL) = (28.7 × HbA1c%) − 46.7.
Diagnostic thresholds per ADA 2024 and RSSDI India guidelines: HbA1c ≥6.5% (48 mmol/mol) = Diabetes. 5.7–6.4% (39–47 mmol/mol) = Prediabetes. Below 5.7% = Normal. Treatment targets in India: HbA1c <7.0% for most adults with type 2 diabetes; <6.5% for younger patients with short disease duration and no hypoglycaemia risk; <8.0% for elderly patients, those with comorbidities, or limited life expectancy.
HbA1c has limitations in conditions that affect red cell turnover — it is falsely low in haemolytic anaemia, recent blood transfusion, and haemoglobinopathies (especially HbS and HbC common in Indian populations), and falsely elevated in iron-deficiency anaemia and chronic kidney disease. In these situations, fructosamine or glycated albumin may be preferred for glycaemic monitoring. HbA1c should be measured every 3 months when glycaemic targets are not met, and every 6 months once stable.